SEBI nod for ₹6,250-cr PharmEasy IPO
The API Holdings IPO will entirely be a fresh issue with only a primary share sale of an unspecified number of shares worth ₹6,250 crore.
api holdings
February 2022
June 2021
How PharmEasy doubled its valuation in two weeks
The first takeover of a listed company, Thyrocare, by a unicorn has helped the online pharmacy startup double its valuation to ₹30,000 crore.
